PhenomeX Inc. announced impairment of goodwill for the second quarter ended June 30, 2023. For the quarter, the company reported loss on impairment of goodwill was $16,557,000.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |